Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 1.57 is 11% below its 3-year average of 1.75, around the middle of its 3-year range (0.01–4.11).
As of the fiscal period ended Tuesday, June 30, 2026. 30.98% above its 12-month average of 1.20.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.57.
QUICK RATIO (ACID-TEST)
1.57
QUICK RATIO (ACID-TEST) AVG TTM
1.20
QUICK RATIO (ACID-TEST) AVG 3Y
1.75
QUICK RATIO (ACID-TEST) AVG 5Y
N/A
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+30.98%
CURRENT VS 3Y AVG
-10.71%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
-53.24%
vs the sector median at left
Medicus Pharma Ltd. Common Stock
Market Cap
$10.10M
Quick Ratio (Acid-Test)
1.57
TTM Avg
1.20
3Y Avg
1.75
5Y Avg
N/A
Market Cap
$10.18M
Quick Ratio (Acid-Test)
1.87
TTM Avg
6.83
3Y Avg
7.99
5Y Avg
8.70
Market Cap
$9.98M
Quick Ratio (Acid-Test)
0.86
TTM Avg
14.33
3Y Avg
8.45
5Y Avg
7.70
Market Cap
$9.97M
Quick Ratio (Acid-Test)
0.83
TTM Avg
3.08
3Y Avg
4.37
5Y Avg
4.67
Market Cap
$9.92M
Quick Ratio (Acid-Test)
11.22
TTM Avg
10.96
3Y Avg
8.46
5Y Avg
6.93
Market Cap
$11.13M
Quick Ratio (Acid-Test)
2.64
TTM Avg
6.08
3Y Avg
6.44
5Y Avg
4.53
Market Cap
$10.52M
Quick Ratio (Acid-Test)
36.37
TTM Avg
19.59
3Y Avg
9.84
5Y Avg
7.09
Market Cap
$9.66M
Quick Ratio (Acid-Test)
1.71
TTM Avg
2.19
3Y Avg
2.80
5Y Avg
3.17
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Medicus Pharma Ltd. Common Stock (MDCX) | $10.10M | 1.57 | 1.20 | 1.75 | N/A |
| Tvardi Therapeutics, Inc. (TVRD)vs › | $10.18M | 1.87 | 6.83 | 7.99 | 8.70 |
| Valion Bio, Inc. (VBIO)vs › | $9.98M | 0.86 | 14.33 | 8.45 | 7.70 |
| Senti Biosciences, Inc. (SNTI)vs › | $9.97M | 0.83 | 3.08 | 4.37 | 4.67 |
| Satellos Bioscience Inc. (MSLE)vs › | $9.92M | 11.22 | 10.96 | 8.46 | 6.93 |
| Ainos, Inc. (AIMD)vs › | $9.79M | 0.12 | 0.92 | 1.12 | 0.77 |
| CytoMed Therapeutics Limited (GDTC)vs › | $11.13M | 2.64 | 6.08 | 6.44 | 4.53 |
| Polyrizon Ltd. (PLRZ)vs › | $10.52M | 36.37 | 19.59 | 9.84 | 7.09 |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $9.66M | 1.71 | 2.19 | 2.80 | 3.17 |
| MetaVia Inc. (MTVA)vs › | $9.62M | 2.06 | 1.94 | 2.63 | 3.51 |
Quick Ratio
1.57
Excludes inventory
Current Ratio
1.57
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 1.57 |
| 2026-03-31 | 1.22 |
| 2025-12-31 | 0.99 |
| 2025-09-30 | 0.92 |
| 2025-06-30 | 1.29 |
| 2025-03-31 | 1.53 |
| 2024-12-31 | 2.33 |
| 2024-09-30 | 2.73 |
| 2024-06-30 | 4.11 |
| 2024-03-31 | 0.50 |
| 2023-12-31 | 2.42 |
| 2023-09-30 | 3.19 |
| 2023-06-30 | 0.01 |
